Glenmark Pharmaceuticals shares tumble nearly 6% over alleged false claims about ‘FabiFlu’
New Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals announced Tuesday that it will commence another new Phase 3 clinical trial. This will be on ...
Read moreDetails
By Aakar Patel Murders committed by the state in India have a name: encounter. Those who carry them out are...
Read moreDetailsBy Dilip Cherian Mallika Srinivasan’s third consecutive one-year extension as chairperson of the Public Enterprises Selection Board (PESB) is increasingly...
Read moreDetailsIt cannot be a coincidence that when the world was still trying to come to terms with the prospect of...
Read moreDetailsLife is getting difficult by the day for Indians with all us citizens reeling under the dual shocks of rising...
Read moreDetails
